Lung Cancer COAST: Durvalumab + Oleclumab/Monalizumab Therapy in Patients with Unresectable NSCLC Apr 17, 2023
Lung Cancer ATEZO-BRAIN: Atezolizumab Plus Carboplatin & Pemetrexed in NSCLC with untreated Brain Metastases Apr 17, 2023
Lung Cancer Efficacy and Safety of Pemigatinib in Pan-Cancer have an Acceptable Safety Profile: FIGHT-101 Apr 17, 2023
Lung Cancer Neoadjuvant Sintilimab Plus Chemotherapy: Two Cycles vs. Three for Resectable NSCLC Apr 17, 2023
Lung Cancer ADRIATIC Phase 3 Study: Combination Therapy with Durvalumab & Tremelimumab in SCLC Mar 30, 2023
Lung Cancer Phase 3 DESTINY-Lung04 Study: T-DXd as First-Line Therapy for HER2-Mutated NSCLC Mar 30, 2023